PI3K Signaling in Normal B Cells and Chronic Lymphocytic Leukemia (CLL) View Full Text


Ontology type: schema:Chapter      Open Access: True


Chapter Info

DATE

2015-09-09

AUTHORS

Klaus Okkenhaug , Jan A. Burger

ABSTRACT

B cells provide immunity to extracellular pathogens by secreting a diverse repertoire of antibodies with high affinity and specificity for exposed antigens. The B cell receptor (BCR) is a transmembrane antibody, which facilitates the clonal selection of B cells producing secreted antibodies of the same specificity. The diverse antibody repertoire is generated by V(D)J recombination of heavy and light chain genes, whereas affinity maturation is mediated by activation-induced cytidine deaminase (AID)-mediated mutagenesis. These processes, which are essential for the generation of adaptive humoral immunity, also render B cells susceptible to chromosomal rearrangements and point mutations that in some cases lead to cancer. In this chapter, we will review the central role of PI3K s in mediating signals from the B cell receptor that not only facilitate the development of functional B cell repertoire, but also support the growth and survival of neoplastic B cells, focusing on chronic lymphocytic leukemia (CLL) B cells. Perhaps because of the central role played by PI3K in BCR signaling, B cell leukemia and lymphomas are the first diseases for which a PI3K inhibitor has been approved for clinical use. More... »

PAGES

123-142

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/82_2015_484

DOI

http://dx.doi.org/10.1007/82_2015_484

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1035404149

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26350103


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "B-Lymphocytes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Lymphocytic, Chronic, B-Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phosphatidylinositol 3-Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Antigen, B-Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Signal Transduction", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Laboratory of Lymphocyte Signaling and Development, The Babraham Institute, Cambridge, CB22 3AT UK", 
          "id": "http://www.grid.ac/institutes/grid.418195.0", 
          "name": [
            "Laboratory of Lymphocyte Signaling and Development, The Babraham Institute, Cambridge, CB22 3AT UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Okkenhaug", 
        "givenName": "Klaus", 
        "id": "sg:person.01356616513.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356616513.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Leukemia, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Leukemia, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Burger", 
        "givenName": "Jan A.", 
        "id": "sg:person.01327752473.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327752473.62"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2015-09-09", 
    "datePublishedReg": "2015-09-09", 
    "description": "B cells provide immunity to extracellular pathogens by secreting a diverse repertoire of antibodies with high affinity and specificity for exposed antigens. The B cell receptor (BCR) is a transmembrane antibody, which facilitates the clonal selection of B cells producing secreted antibodies of the same specificity. The diverse antibody repertoire is generated by V(D)J recombination of heavy and light chain genes, whereas affinity maturation is mediated by activation-induced cytidine deaminase (AID)-mediated mutagenesis. These processes, which are essential for the generation of adaptive humoral immunity, also render B cells susceptible to chromosomal rearrangements and point mutations that in some cases lead to cancer. In this chapter, we will review the central role of PI3K s in mediating signals from the B cell receptor that not only facilitate the development of functional B cell repertoire, but also support the growth and survival of neoplastic B cells, focusing on chronic lymphocytic leukemia (CLL) B cells. Perhaps because of the central role played by PI3K in BCR signaling, B cell leukemia and lymphomas are the first diseases for which a PI3K inhibitor has been approved for clinical use.", 
    "editor": [
      {
        "familyName": "Kurosaki", 
        "givenName": "Tomohiro", 
        "type": "Person"
      }, 
      {
        "familyName": "Wienands", 
        "givenName": "J\u00fcrgen", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/82_2015_484", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": {
      "isbn": [
        "978-3-319-26131-7", 
        "978-3-319-26133-1"
      ], 
      "name": "B Cell Receptor Signaling", 
      "type": "Book"
    }, 
    "keywords": [
      "activation-induced cytidine deaminase", 
      "PI3K signaling", 
      "chronic lymphocytic leukemia", 
      "Normal B Cells", 
      "cell receptor", 
      "light chain genes", 
      "central role", 
      "PI3K inhibitors", 
      "chromosomal rearrangements", 
      "chronic lymphocytic leukemia B cells", 
      "BCR signaling", 
      "PI3K", 
      "B cells", 
      "point mutations", 
      "diverse antibody repertoire", 
      "chain gene", 
      "cytidine deaminase", 
      "extracellular pathogens", 
      "diverse repertoire", 
      "leukemia B cells", 
      "adaptive humoral immunity", 
      "signaling", 
      "clonal selection", 
      "cells", 
      "humoral immunity", 
      "same specificity", 
      "cell repertoire", 
      "lymphocytic leukemia", 
      "repertoire", 
      "antibody repertoire", 
      "cell leukemia", 
      "high affinity", 
      "clinical use", 
      "secreted antibodies", 
      "affinity maturation", 
      "first disease", 
      "mutagenesis", 
      "antibodies", 
      "genes", 
      "receptors", 
      "leukemia", 
      "immunity", 
      "mutations", 
      "pathogens", 
      "recombination", 
      "specificity", 
      "role", 
      "maturation", 
      "deaminase", 
      "rearrangement", 
      "inhibitors", 
      "lymphoma", 
      "affinity", 
      "cancer", 
      "growth", 
      "antigen", 
      "disease", 
      "survival", 
      "selection", 
      "signals", 
      "development", 
      "cases", 
      "generation", 
      "process", 
      "use", 
      "chapter", 
      "transmembrane antibody", 
      "PI3K s", 
      "K s", 
      "lymphocytic leukemia (CLL) B cells", 
      "K inhibitor", 
      "K Signaling"
    ], 
    "name": "PI3K Signaling in Normal B Cells and Chronic Lymphocytic Leukemia (CLL)", 
    "pagination": "123-142", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1035404149"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/82_2015_484"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26350103"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/82_2015_484", 
      "https://app.dimensions.ai/details/publication/pub.1035404149"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2021-11-01T19:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/chapter/chapter_447.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/82_2015_484"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/82_2015_484'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/82_2015_484'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/82_2015_484'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/82_2015_484'


 

This table displays all metadata directly associated to this object as RDF triples.

191 TRIPLES      23 PREDICATES      107 URIs      98 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/82_2015_484 schema:about N061c0c3196e245f2825f0560d07d09ce
2 N0f0c23264d354614a09624b6d0497d93
3 N2e2ea4329aa14de2b870a74c96767f2e
4 N5688e168cbe942bc9c112bb5e2609809
5 N64e1a226375244d99429c067faff6fc1
6 N8624175f30274aa1a509d4da1d22abd7
7 N8d87874ebbb5428691c56dc89e835925
8 N9d8e5e81440d47e3a1e00083291631d6
9 anzsrc-for:06
10 anzsrc-for:0601
11 anzsrc-for:11
12 anzsrc-for:1107
13 schema:author N0a583fe07b62477e836aed0a58ddc373
14 schema:datePublished 2015-09-09
15 schema:datePublishedReg 2015-09-09
16 schema:description B cells provide immunity to extracellular pathogens by secreting a diverse repertoire of antibodies with high affinity and specificity for exposed antigens. The B cell receptor (BCR) is a transmembrane antibody, which facilitates the clonal selection of B cells producing secreted antibodies of the same specificity. The diverse antibody repertoire is generated by V(D)J recombination of heavy and light chain genes, whereas affinity maturation is mediated by activation-induced cytidine deaminase (AID)-mediated mutagenesis. These processes, which are essential for the generation of adaptive humoral immunity, also render B cells susceptible to chromosomal rearrangements and point mutations that in some cases lead to cancer. In this chapter, we will review the central role of PI3K s in mediating signals from the B cell receptor that not only facilitate the development of functional B cell repertoire, but also support the growth and survival of neoplastic B cells, focusing on chronic lymphocytic leukemia (CLL) B cells. Perhaps because of the central role played by PI3K in BCR signaling, B cell leukemia and lymphomas are the first diseases for which a PI3K inhibitor has been approved for clinical use.
17 schema:editor N051b982add73407182daf6e60e0da046
18 schema:genre chapter
19 schema:inLanguage en
20 schema:isAccessibleForFree true
21 schema:isPartOf Nec3009bb4b5a4432ae1a2791318aff91
22 schema:keywords B cells
23 BCR signaling
24 K Signaling
25 K inhibitor
26 K s
27 Normal B Cells
28 PI3K
29 PI3K inhibitors
30 PI3K s
31 PI3K signaling
32 activation-induced cytidine deaminase
33 adaptive humoral immunity
34 affinity
35 affinity maturation
36 antibodies
37 antibody repertoire
38 antigen
39 cancer
40 cases
41 cell leukemia
42 cell receptor
43 cell repertoire
44 cells
45 central role
46 chain gene
47 chapter
48 chromosomal rearrangements
49 chronic lymphocytic leukemia
50 chronic lymphocytic leukemia B cells
51 clinical use
52 clonal selection
53 cytidine deaminase
54 deaminase
55 development
56 disease
57 diverse antibody repertoire
58 diverse repertoire
59 extracellular pathogens
60 first disease
61 generation
62 genes
63 growth
64 high affinity
65 humoral immunity
66 immunity
67 inhibitors
68 leukemia
69 leukemia B cells
70 light chain genes
71 lymphocytic leukemia
72 lymphocytic leukemia (CLL) B cells
73 lymphoma
74 maturation
75 mutagenesis
76 mutations
77 pathogens
78 point mutations
79 process
80 rearrangement
81 receptors
82 recombination
83 repertoire
84 role
85 same specificity
86 secreted antibodies
87 selection
88 signaling
89 signals
90 specificity
91 survival
92 transmembrane antibody
93 use
94 schema:name PI3K Signaling in Normal B Cells and Chronic Lymphocytic Leukemia (CLL)
95 schema:pagination 123-142
96 schema:productId N4be9f6a9b1314fbb81b503d7bf427aa6
97 N9b4e0f75160f441eaabb6db05cbf8c51
98 Nfbdec51c175746d098a271ded8bf99c3
99 schema:publisher Nd9b5670b8d4f4b4db7f0d1b87c4ae965
100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035404149
101 https://doi.org/10.1007/82_2015_484
102 schema:sdDatePublished 2021-11-01T19:01
103 schema:sdLicense https://scigraph.springernature.com/explorer/license/
104 schema:sdPublisher N23475b126546415098638876b18ccebe
105 schema:url https://doi.org/10.1007/82_2015_484
106 sgo:license sg:explorer/license/
107 sgo:sdDataset chapters
108 rdf:type schema:Chapter
109 N051b982add73407182daf6e60e0da046 rdf:first N657d17ee209c4704a57d05c551770ed8
110 rdf:rest N66d4028c14b74e56829e342b1a1aef6c
111 N061c0c3196e245f2825f0560d07d09ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name B-Lymphocytes
113 rdf:type schema:DefinedTerm
114 N0a583fe07b62477e836aed0a58ddc373 rdf:first sg:person.01356616513.06
115 rdf:rest Ncb590cea0f2648f084d1af41b44ccf86
116 N0f0c23264d354614a09624b6d0497d93 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Cell Survival
118 rdf:type schema:DefinedTerm
119 N23475b126546415098638876b18ccebe schema:name Springer Nature - SN SciGraph project
120 rdf:type schema:Organization
121 N2e2ea4329aa14de2b870a74c96767f2e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Phosphatidylinositol 3-Kinases
123 rdf:type schema:DefinedTerm
124 N4be9f6a9b1314fbb81b503d7bf427aa6 schema:name pubmed_id
125 schema:value 26350103
126 rdf:type schema:PropertyValue
127 N5688e168cbe942bc9c112bb5e2609809 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Humans
129 rdf:type schema:DefinedTerm
130 N64e1a226375244d99429c067faff6fc1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Leukemia, Lymphocytic, Chronic, B-Cell
132 rdf:type schema:DefinedTerm
133 N657d17ee209c4704a57d05c551770ed8 schema:familyName Kurosaki
134 schema:givenName Tomohiro
135 rdf:type schema:Person
136 N66d4028c14b74e56829e342b1a1aef6c rdf:first Ne9314d641f20434ca2a4f5f79f752837
137 rdf:rest rdf:nil
138 N8624175f30274aa1a509d4da1d22abd7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Receptors, Antigen, B-Cell
140 rdf:type schema:DefinedTerm
141 N8d87874ebbb5428691c56dc89e835925 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Signal Transduction
143 rdf:type schema:DefinedTerm
144 N9b4e0f75160f441eaabb6db05cbf8c51 schema:name doi
145 schema:value 10.1007/82_2015_484
146 rdf:type schema:PropertyValue
147 N9d8e5e81440d47e3a1e00083291631d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Animals
149 rdf:type schema:DefinedTerm
150 Ncb590cea0f2648f084d1af41b44ccf86 rdf:first sg:person.01327752473.62
151 rdf:rest rdf:nil
152 Nd9b5670b8d4f4b4db7f0d1b87c4ae965 schema:name Springer Nature
153 rdf:type schema:Organisation
154 Ne9314d641f20434ca2a4f5f79f752837 schema:familyName Wienands
155 schema:givenName Jürgen
156 rdf:type schema:Person
157 Nec3009bb4b5a4432ae1a2791318aff91 schema:isbn 978-3-319-26131-7
158 978-3-319-26133-1
159 schema:name B Cell Receptor Signaling
160 rdf:type schema:Book
161 Nfbdec51c175746d098a271ded8bf99c3 schema:name dimensions_id
162 schema:value pub.1035404149
163 rdf:type schema:PropertyValue
164 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
165 schema:name Biological Sciences
166 rdf:type schema:DefinedTerm
167 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
168 schema:name Biochemistry and Cell Biology
169 rdf:type schema:DefinedTerm
170 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
171 schema:name Medical and Health Sciences
172 rdf:type schema:DefinedTerm
173 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
174 schema:name Immunology
175 rdf:type schema:DefinedTerm
176 sg:person.01327752473.62 schema:affiliation grid-institutes:grid.240145.6
177 schema:familyName Burger
178 schema:givenName Jan A.
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327752473.62
180 rdf:type schema:Person
181 sg:person.01356616513.06 schema:affiliation grid-institutes:grid.418195.0
182 schema:familyName Okkenhaug
183 schema:givenName Klaus
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356616513.06
185 rdf:type schema:Person
186 grid-institutes:grid.240145.6 schema:alternateName Department of Leukemia, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 USA
187 schema:name Department of Leukemia, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 USA
188 rdf:type schema:Organization
189 grid-institutes:grid.418195.0 schema:alternateName Laboratory of Lymphocyte Signaling and Development, The Babraham Institute, Cambridge, CB22 3AT UK
190 schema:name Laboratory of Lymphocyte Signaling and Development, The Babraham Institute, Cambridge, CB22 3AT UK
191 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...